Non-steroidal anti-inflammatory drugs and cardiovascular risk : a rheumatologist's reply
Date
2007-12
Authors
Whitelaw, David
Journal Title
Journal ISSN
Volume Title
Publisher
Health and Medical Publishing Group (HMPG)
Abstract
To the Editor: The cyclo-oxygenase-2 (COX-2) inhibitors and
other non-steroidal anti-inflammatory drugs (NSAIDs) have
been the subject of scrutiny generated mainly by evidence
suggesting that rofecoxib is associated with increased
cardiovascular risk. Chin and Commerford1 have summarised
some of the large volume of data; however, a critical review of
published work yields interesting insights.
Description
Letter
The original publication is available at http://www.samj.org.za
The original publication is available at http://www.samj.org.za
Keywords
Nonsteroidal anti-inflammatory agents, Cardiovascular system -- Diseases
Citation
Whitelaw, D. 2007. Non-steroidal anti-inflammatory drugs and cardiovascular risk - a rheumatologist's reply. South African Medical Journal, 97(12):1230.